Tag: Russia

Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON; the “Company” or “VEON”), a global digital operator, today announces that Omiyinka Doris has chosen to step aside from her role as Group General Counsel of the Company effective July 1, 2025. Ms. Doris will continue as a strategic advisor to the Group Chief Executive Officer and will remain based in Amsterdam.

New York City, NJ, June 13, 2025 (GLOBE NEWSWIRE) --

The cryptocurrency market is undergoing a new round of explosive changes—Bitcoin has broken through the $100,000 mark, the US has relaxed regulations, and Russia has fully legalised mining. These monumental shifts are reshaping the global financial landscape. In response, cloud mining is increasingly recognized as a pivotal pathway for ordinary investors seeking entry into the market, offering compelling advantages such as zero hardware investment and freedom from ongoing operation and maintenance costs. The following key trends and strategies will help you seize the unique opportunities presented by this evolving digital economy.

BEIJING, June 12, 2025 (GLOBE NEWSWIRE) -- The eighth “International Editors-in-Chief Roundtable,” hosted by Global Times and Global Times Online (huanqiu.com), brought together media leaders from China, Russia, Pakistan, Canada, Nepal, Syria, and Ghana to explore global trends. Amid ongoing global shifts, participants highlighted the value of inclusive globalization and diversified cooperation.

MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech’s proven track record and established position in the global mRNA industry.